OPKO HEALTH INC (OPK) Stock Fundamental Analysis
USA - NASDAQ:OPK - US68375N1037 - Common Stock
1.33 USD
0 (0%)
Taking everything into account, OPK scores 2 out of 10 in our fundamental rating. OPK was compared to 100 industry peers in the Health Care Providers & Services industry. OPK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OPK is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year OPK has reported negative net income.
OPK had a negative operating cash flow in the past year.
OPK had negative earnings in 4 of the past 5 years.
In multiple years OPK reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -9.04%, OPK is doing worse than 76.00% of the companies in the same industry.
OPK's Return On Equity of -13.82% is on the low side compared to the rest of the industry. OPK is outperformed by 64.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.04% | ||
| ROE | -13.82% | ||
| ROIC | N/A |
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OPK has a better Gross Margin (35.29%) than 65.00% of its industry peers.
In the last couple of years the Gross Margin of OPK has declined.
OPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 35.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
2. Health
2.1 Basic Checks
OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
OPK has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, OPK has more shares outstanding
The debt/assets ratio for OPK is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.42, we must say that OPK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.42, OPK is not doing good in the industry: 81.00% of the companies in the same industry are doing better.
OPK has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
OPK has a better Debt to Equity ratio (0.26) than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.42 |
ROIC/WACCN/A
WACC9%
2.3 Liquidity
OPK has a Current Ratio of 3.70. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.70, OPK belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
A Quick Ratio of 3.32 indicates that OPK has no problem at all paying its short term obligations.
OPK has a better Quick ratio (3.32) than 88.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.7 | ||
| Quick Ratio | 3.32 |
3. Growth
3.1 Past
OPK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.35%, which is quite good.
OPK shows a decrease in Revenue. In the last year, the revenue decreased by -9.75%.
OPK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.59% yearly.
EPS 1Y (TTM)19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)-9.75%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-12.62%
3.2 Future
The Earnings Per Share is expected to grow by 16.75% on average over the next years. This is quite good.
OPK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.51% yearly.
EPS Next Y-64.33%
EPS Next 2Y-10.74%
EPS Next 3Y16.75%
EPS Next 5YN/A
Revenue Next Year-12.6%
Revenue Next 2Y-8.79%
Revenue Next 3Y-3.56%
Revenue Next 5Y0.51%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
OPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OPK's earnings are expected to grow with 16.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.74%
EPS Next 3Y16.75%
5. Dividend
5.1 Amount
OPK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:OPK (11/11/2025, 3:49:50 PM)
1.33
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners26.32%
Inst Owner Change-0.35%
Ins Owners5.17%
Ins Owner Change0%
Market Cap1.06B
Revenue(TTM)642.07M
Net Income(TTM)-180.40M
Analysts82
Price Target3.98 (199.25%)
Short Float %7.91%
Short Ratio15.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)50.01%
Min EPS beat(2)-65.99%
Max EPS beat(2)166.01%
EPS beat(4)2
Avg EPS beat(4)41.56%
Min EPS beat(4)-65.99%
Max EPS beat(4)166.01%
EPS beat(8)4
Avg EPS beat(8)29.25%
EPS beat(12)7
Avg EPS beat(12)30.6%
EPS beat(16)7
Avg EPS beat(16)-123.82%
Revenue beat(2)0
Avg Revenue beat(2)-6.44%
Min Revenue beat(2)-6.58%
Max Revenue beat(2)-6.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)16.97%
Revenue beat(8)2
Avg Revenue beat(8)-2.26%
Revenue beat(12)6
Avg Revenue beat(12)3.66%
Revenue beat(16)7
Avg Revenue beat(16)3.33%
PT rev (1m)0%
PT rev (3m)26.21%
EPS NQ rev (1m)2.57%
EPS NQ rev (3m)-22.57%
EPS NY rev (1m)10.09%
EPS NY rev (3m)1.91%
Revenue NQ rev (1m)-14.58%
Revenue NQ rev (3m)-15.51%
Revenue NY rev (1m)-5.24%
Revenue NY rev (3m)-7.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.64 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.81 | ||
| P/tB | 11.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.81
BVpS1.64
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.04% | ||
| ROE | -13.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 35.29% | ||
| FCFM | N/A |
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
F-Score5
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 16.11% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.7 | ||
| Quick Ratio | 3.32 | ||
| Altman-Z | -0.42 |
F-Score5
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)28.79%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y-64.33%
EPS Next 2Y-10.74%
EPS Next 3Y16.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.75%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-12.62%
Revenue Next Year-12.6%
Revenue Next 2Y-8.79%
Revenue Next 3Y-3.56%
Revenue Next 5Y0.51%
EBIT growth 1Y30.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.92%
EBIT Next 3Y30.43%
EBIT Next 5Y23.26%
FCF growth 1Y-414.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-816.42%
OCF growth 3YN/A
OCF growth 5YN/A
OPKO HEALTH INC / OPK FAQ
Can you provide the ChartMill fundamental rating for OPKO HEALTH INC?
ChartMill assigns a fundamental rating of 2 / 10 to OPK.
Can you provide the valuation status for OPKO HEALTH INC?
ChartMill assigns a valuation rating of 0 / 10 to OPKO HEALTH INC (OPK). This can be considered as Overvalued.
What is the profitability of OPK stock?
OPKO HEALTH INC (OPK) has a profitability rating of 1 / 10.
How financially healthy is OPKO HEALTH INC?
The financial health rating of OPKO HEALTH INC (OPK) is 5 / 10.
What is the earnings growth outlook for OPKO HEALTH INC?
The Earnings per Share (EPS) of OPKO HEALTH INC (OPK) is expected to decline by -64.33% in the next year.